EUVIMEDEUVIMED entdecken
Crossref

Dual role of LY96 in shaping the mesenchymal glioblastoma ecosystem through stem cell maintenance and macrophage MES-like reprogramming

Danyang Shan, Chenfei Lu, Hang Yu, Daqi Li, Gaoyuan Cui, Zhengjun Zhou, Zhe Zhu, Markus D Siegelin, Jingshan Liang, Qian Zhang, Jeremy N Rich, Xiuxing Wang und 4 weitere

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Danyang Shan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trials Center, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, China. Hauptthemen laut MEDLINE: Glioblastoma, Neoplastic Stem Cells, Brain Neoplasms, Tumor-Associated Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Southeast University, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is highly heterogeneous, complicating effective tumor elimination. Among GBM subtypes, the mesenchymal (MES) variant is associated with the poorest prognosis. Notably, macrophage infiltration is significantly higher in MES GBM. However, the regulatory networks underlying this distinct MES GBM microenvironment remain poorly understood. Here, we demonstrate that MES glioblastoma stem cells (GSCs) exhibit a preferential expression and secretion of the protein LY96. Mechanistically, MES GSCs engage an autocrine LY96-TNFRSF1B signaling axis that activates NF-κB, thereby promoting their proliferation, self-renewal, and maintenance of the MES state. Inhibition of LY96 in vivo suppresses GBM growth and prolongs survival in animal models. Additionally, LY96 acts in a paracrine manner on tumor-associated macrophages (TAMs), driving their polarization toward a MES-like state. Collectively, our findings identify LY96 as a key regulator of the MES state in GSCs and a driver of MES-like polarization in TAMs. Therapeutic strategies targeting LY96 and its downstream effectors may improve GBM treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNeoplastic Stem CellsBrain NeoplasmsTumor-Associated MacrophagesMacrophagesMesenchymal Stem CellsHumansAnimalsCell ProliferationSignal TransductionTumor MicroenvironmentNF-kappa BCell Line, TumorCellular ReprogrammingParacrine CommunicationMiceCell Self Renewal

Substanzen

NF-kappa B

Autor:innen und Institutionen

  • Clinical Trials Center, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; National Health Commission Key Laboratory of Antibody Techniques, Department of Cell Biology, Jian…
  • National Health Commission Key Laboratory of Antibody Techniques, Department of Cell Biology, Jiangsu Provincial Key Laboratory of Human Functional Genomics, School of Basic Medical Sciences, Nanjing Medical University,…
  • Department of Neurosurgery, The Affiliated Hospital, Southwest Medical University, Luzhou 646000, China; Sichuan Clinical Research Center for Neurosurgery, The Affiliated Hospital, Southwest Medical University, Luzhou 6…
  • Department of Pathology and Cell Biology, Columbia University Medical Center, New York NY 10032, USA.
  • Department of Neurosurgery, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222001, China.

Förderung

  • Southeast University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • National Science Foundation
  • Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau
  • Columbia University

Zitieren

APA

Shan, D., Lu, C., Yu, H., Li, D., Cui, G., Zhou, Z., Zhu, Z., Siegelin, M. D., Liang, J., Zhang, Q., Rich, J. N., Wang, X., Wang, X., Liu, Y., Zhou, J., & Yang, K. (2026). Dual role of LY96 in shaping the mesenchymal glioblastoma ecosystem through stem cell maintenance and macrophage MES-like reprogramming. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218409

Vancouver

Shan D, Lu C, Yu H, Li D, Cui G, Zhou Z, et al. Dual role of LY96 in shaping the mesenchymal glioblastoma ecosystem through stem cell maintenance and macrophage MES-like reprogramming. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218409

BibTeX
@article{Shan2026,
  author = {Shan, Danyang and Lu, Chenfei and Yu, Hang and Li, Daqi and Cui, Gaoyuan and Zhou, Zhengjun and Zhu, Zhe and Siegelin, Markus D and Liang, Jingshan and Zhang, Qian and Rich, Jeremy N and Wang, Xiuxing and Wang, Xiefeng and Liu, Yanyan and Zhou, Jie and Yang, Kun},
  title = {Dual role of LY96 in shaping the mesenchymal glioblastoma ecosystem through stem cell maintenance and macrophage MES-like reprogramming},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218409}
}
Kostenlos starten →